S H Kelkar and Company Limited has informed the Exchange regarding Re-appointment of Mr Kedar Vaze as Whole-time Director & Group CEO of the company for a period of three years from September 01, 2025.
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 12.3 pts more than Nifty Microcap 250 and 12.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved audited consolidated and standalone financial results for Q4 and FY25. Consolidated revenue from operations grew to ₹2,123.40 crores from ₹1,840.83 crores, but profit for the year fell sharply to ₹73.01 crores from ₹123.55 crores, mainly due to an exceptional loss of ₹60.55 crores linked to a major fire at the Vashivali plant in April 2024 (total carrying value loss of ₹160.18 crores, partially offset by ₹95 crores insurance interim relief). The Board recommended a final dividend of Re. 1 per share (10%) for FY25, subject to AGM approval, with the 69th AGM scheduled for August 12, 2025. Mr. Kedar Vaze was re-appointed as Whole-time Director & Group CEO for three years from September 1, 2025, and Ms. Pallavi Gokhale was appointed as an Additional Non-Executive Non-Independent Director from July 1, 2025. The Board also approved the incorporation of a wholly owned subsidiary, Keva Middle East FZE, in the UAE, and appointed new secretarial, internal, and cost auditors for FY26.
Strong revenue growth is a positive, but the sharp drop in net profit due to the Vashivali fire loss (even with partial insurance recovery) is a concern for shareholders. The final dividend of Re. 1 per share offers modest income. CEO continuity and UAE expansion signal strategic stability and growth focus.